Health Care·Health Care Supplies·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.71 | N/A | -0.98% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.98% |
Tone: Defensive
Management expressed concerns about market conditions impacting performance. They are prioritizing efficiency to navigate these challenges.
Management acknowledged challenges in the current market environment.
They emphasized a focus on operational efficiency moving forward.
Haemonetics Corp's earnings report shows a slight miss on EPS, which contributed to a 6.04% drop in stock price. The lack of revenue data and guidance may raise concerns among investors about future performance. Management's defensive tone suggests they are facing challenges in the market, which could impact growth moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
IDEXX LABS INC
Jan 29, 2010